The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 29th 2024
The combined effects of cagrilintide and semaglutide in CagriSema offer a dual approach to weight loss and glucose regulation.
Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies
May 14th 2015The companies will investigate potential therapeutics using biotechnology approaches in targeting multiple immune checkpoint modulators for the treatment of immunological diseases such as lupus, Sjögren's Syndrome, inflammatory bowel disease and other autoimmune disorders.
Read More